Welcome Guest

Table of Contents

Volume 4 |  Issue 2

Publication Date: September 2002
  • Abstract
  • No Access
  • Pay-Per View
  • Full Text
  • Add to Cart


Editorial

75
Impact of INTACT: Do We Change the Target or the Aim?
Sakkaraiappan Ramalingam, Chandra P. Belani
Researches in Brief

76-79
Gemcitabine/Carboplatin in Advanced Non–Small-Cell Lung Cancer: Data from Randomized Phase III Trials
Amy D’Orazio, Chandra P. Belani

80-82
Cell-Cycle Inhibitors as Novel Therapies for Lung Cancer
Heather DeGrendele, Chandra P. Belani, Geoffrey Shapiro, Michael C. Perry
Comprehensive Review

87-94
Small-Cell Lung Cancer: State of the Art
Nasser H. Hanna, Lawrence H. Einhorn
Original Contributions

95-103
Radiotherapy Versus Chemotherapy Plus Radiotherapy in Surgically Treated IIIA N2 Non–Small-Cell Lung Cancer
Anthony D. Elias, Parvesh Kumar, James Herndon III, Arthur T. Skarin, David J. Sugarbaker, Mark R. Green, for the Cancer and Leukemia Group B

104-109
Real-Time Clinical Application of Quality-of-Life Assessment in Advanced Lung Cancer
Chih-Hung Chang, David Cella, Gregory A. Masters, Nicole Laliberte, Paul O’Brien, Amy Peterman, Daniel Shevrin
Commentary

110
The Importance of Quality-of-Life Measurements in Oncology
J. Lee Villano, Marcy A. List, Everett E. Vokes
Translational Medicine

111-123
Promising Developments in Targeted Therapies for Non–Small-Cell Lung Cancer
Desirée Hao, Manuel Hidalgo
Commentary

124
“Targeted” Therapies for Non–Small-Cell Lung Cancer
Alex A. Adjei
  1. https://www.ceteresopolitano.org/
  2. https://www.crossingstoronto.com/
  3. https://www.jediism.org/
  4. https://www.badenumc.org/
  5. https://www.johnsevierchapter.org/
  6. https://www.trinitychapelmn.org/
  7. https://www.photogearnews.com/
  8. https://www.alz-nova.org/
  9. https://www.cigjournals.com/
  10. https://summa-edu.com/
  11. https://cpawilmingtonnc.org/
  12. https://bimometals.com/
  13. https://sosenvironmental.com/
  14. https://thefriary.org/
  15. https://post5theatre.org/
  1. Pengeluaran SDY